SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001019687-15-001897
Filing Date
2015-05-13
Accepted
2015-05-13 11:33:58
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT proteo_10q-033115.htm 10-Q 158484
2 CERTIFICATION proteo_10q-ex3101.htm EX-31.1 9243
3 CERTIFICATION proteo_10q-ex3102.htm EX-31.2 9374
4 CERTIFICATION proteo_10q-ex32.htm EX-32 5449
  Complete submission text file 0001019687-15-001897.txt   1156823

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE pteo-20150331.xml EX-101.INS 77907
6 XBRL SCHEMA FILE pteo-20150331.xsd EX-101.SCH 11859
7 XBRL CALCULATION FILE pteo-20150331_cal.xml EX-101.CAL 26055
8 XBRL DEFINITION FILE pteo-20150331_def.xml EX-101.DEF 9388
9 XBRL LABEL FILE pteo-20150331_lab.xml EX-101.LAB 85254
10 XBRL PRESENTATION FILE pteo-20150331_pre.xml EX-101.PRE 64371
Mailing Address 2102 BUSINESS CENTER DRIVE IRVINE CA 92612
Business Address 2102 BUSINESS CENTER DRIVE IRVINE CA 92612 949-253-4616
PROTEO INC (Filer) CIK: 0001063104 (see all company filings)

IRS No.: 880292249 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30728 | Film No.: 15857115
SIC: 2834 Pharmaceutical Preparations